Quality, clinical governance & evidence
Show the evidence.Accredit every step.Keep clinicians in charge.
Our rule
Everyreportreviewedandsignedbythetreatingoncologist—thentakentoKPCIRC'sMolecularTumourBoard.
Governance areas
Five areas, each with its own page
- Clinical interpretationKPCIRC sign-off & oncologist ownershipWho reviews, who signs, the Molecular Tumour Board, and why the treating oncologist owns every decision.Read more
- EvidenceClinical evidenceAnalytical validity, clinical validity, clinical utility and functional evidence — capability by capability.Read more
- QualityQuality & accreditationCAP- and NABL-accredited, ISO-certified laboratories, with HIPAA- and GDPR-compliant data handling.Read more
- Intended useIntended use & research boundariesTwin's clinician-led positioning and AVATAR's research-use status, stated without overlap.Read more
- DataPrivacy & responsible data useConsent, genomic and health data, access, sharing, retention and research use.Read more
- ScienceVariant interpretation & evidenceDetection, annotation, association and actionability — and why they are not the same.Read more
Accreditation and compliance
Clinical ownership
Clinical ownership
The treating oncologist owns everything.
“The Clinical Twin belongs to the treating oncologist and their patient.” OnKommon organises the evidence; the oncologist reviews it, signs it and makes every decision.
You decide
Clinical authority stays with you.
You review and sign
Every report reviewed and signed by you.
You control access
Access follows your approved workflow.
The Twin evolves with you
New evidence can prompt reassessment.
Layers of assurance
Quality, built in at every level
Accredited laboratories
CAP and NABL accreditation, assessed laboratory by laboratory for a defined scope of tests.
Certified systems
ISO-certified quality management across sample handling, analysis, reporting and review.
Validated assays
Every assay is validated for accuracy, sensitivity and limits of detection before it reports a result.
Governed software
The Twin platform is versioned, tested and change-controlled — and every report is signed by the treating oncologist.